Skip to main content

UBS Group AG

Position in XERS — Xeris Biopharma Holdings, Inc.

CIK 1610520 ZURICH, V8

Position in XERS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$10,303,229
+$754,238 QoQ
Shares Held
1,300,913
-21.0% QoQ
Ownership
0.714%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#23
of 238 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in XERS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. XERS ranks #20 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in XERS

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,303,229 1,300,913
2026-03-31 $9,548,991 1,646,378
2025-12-31 $4,724,395 601,834
2025-09-30 $14,511,453 1,782,734
2025-06-30 $1,064,129 227,865
2025-03-31 $4,742,128 863,776
2024-12-31 $5,879,922 1,734,491
2024-09-30 $807,267 283,252
2024-06-30 $368,186 163,639
2024-03-31 $434,512 196,613
2023-12-31 $315,867 134,412
2023-09-30 $138,458 74,440
2023-06-30 $8,795 3,357
2023-03-31 $77,945 47,820
2022-12-31 $34,729 26,113
2022-09-30 $23,473 15,048
2022-06-30 $4,707 3,057
2022-03-31 $128,898 50,351
2021-12-31 $37,011 12,632